Abstract
The three-dimensional structure of the anti-apoptotic protein Bcl-xL complexed to a 25-residue peptide from the death promoting region of Bad was determined using NMR spectroscopy. Although the overall structure is similar to Bcl-xL bound to a 16-residue peptide from the Bak protein (Sattler et al., 1997), the Bad peptide forms additional interactions with Bcl-xL. However, based upon site-directed mutagenesis experiments, these additional contacts do not account for the increased affinity of the Bad 25-mer for Bcl-xL compared to the Bad 16-mer. Rather, the increased helix propensity of the Bad 25-mer is primarily responsible for its greater affinity for Bcl-xL. Based on this observation, a pair of 16-residue peptides were designed and synthesized that were predicted to have a high helix propensity while maintaining the interactions important for complexation with Bcl-xL. Both peptides showed an increase in helix propensity compared to the wild-type and exhibited an enhanced affinity for Bcl-xL.
MeSH Terms
Amino Acid Sequence
Apoptosis
Binding Sites
Carrier Proteins/chemistry,metabolism
Humans
Models, Molecular
Mutagenesis, Site-Directed
Nuclear Magnetic Resonance, Biomolecular
Peptides/chemical synthesis,metabolism
Protein Binding
Protein Engineering
Protein Structure, Secondary
Protein Structure, Tertiary
Proto-Oncogene Proteins c-bcl-2/chemistry,metabolism
Structure-Activity Relationship
bcl-Associated Death Protein
bcl-X Protein
Chemicals
BAD protein, human
BCL2L1 protein, human
Carrier Proteins
Peptides
Proto-Oncogene Proteins c-bcl-2
bcl-Associated Death Protein
bcl-X Protein
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Petros A M
Pharmaceutical Discovery Division, Abbott Laboratories, Abbott Park, Illinois 60064-6098, USA.
Nettesheim D G
Wang Y
Olejniczak E T
Meadows R P
Mack J
Swift K
Matayoshi E D
Zhang H
Thompson C B
Fesik S W
References (21)
21 references, click to expand
-
Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity.
Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9373-8
PMID: 10944210
-
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11000-7
PMID: 10500114
-
Equilibrium and kinetic inhibition assays based upon fluorescence polarization.
Methods Enzymol. 1981;74 Pt C:3-28
PMID: 7321886
-
Stereospecific nuclear magnetic resonance assignments of the methyl groups of valine and leucine in the DNA-binding domain of the 434 repressor by biosynthetically directed fractional 13C labeling.
Biochemistry. 1989 Sep 19;28(19):7510-6
PMID: 2692701
-
Side chain and backbone assignments in isotopically labeled proteins from two heteronuclear triple resonance experiments.
FEBS Lett. 1992 Dec 21;314(3):413-8
PMID: 1281793
-
Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death.
Cell. 1995 Jan 27;80(2):285-91
PMID: 7834748
-
Elucidating the folding problem of helical peptides using empirical parameters. II. Helix macrodipole effects and rational modification of the helical content of natural peptides.
J Mol Biol. 1995 Jan 20;245(3):275-96
PMID: 7844817
-
Elucidating the folding problem of helical peptides using empirical parameters. III. Temperature and pH dependence.
J Mol Biol. 1995 Jan 20;245(3):297-308
PMID: 7844818
-
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death.
Nature. 1996 May 23;381(6580):335-41
PMID: 8692274
-
Helix propagation and N-cap propensities of the amino acids measured in alanine-based peptides in 40 volume percent trifluoroethanol.
Protein Sci. 1996 Dec;5(12):2623-37
PMID: 8976571
-
AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR.
J Biomol NMR. 1996 Dec;8(4):477-86
PMID: 9008363
-
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis.
Science. 1997 Feb 14;275(5302):983-6
PMID: 9020082
-
Helix propensities are identical in proteins and peptides.
Biochemistry. 1997 Sep 9;36(36):10923-9
PMID: 9283083
-
Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL.
Mol Cell Biol. 1997 Dec;17(12):7040-6
PMID: 9372935
-
Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins.
J Biol Chem. 1997 Dec 5;272(49):30866-72
PMID: 9388232
-
Torsion-angle molecular dynamics as a new efficient tool for NMR structure calculation.
J Magn Reson. 1997 Jan;124(1):154-64
PMID: 9424305
-
The Bcl-2 protein family: arbiters of cell survival.
Science. 1998 Aug 28;281(5381):1322-6
PMID: 9735050
-
Recent progress on the regulation of apoptosis by Bcl-2 family members.
Adv Immunol. 1998;70:245-79
PMID: 9755339
-
Protein backbone angle restraints from searching a database for chemical shift and sequence homology.
J Biomol NMR. 1999 Mar;13(3):289-302
PMID: 10212987
-
Structure-based design, synthesis, and X-ray crystallography of a high-affinity antagonist of the Grb2-SH2 domain containing an asparagine mimetic.
J Med Chem. 1999 Jul 1;42(13):2358-63
PMID: 10395476
-
Cleavage at cysteine after cyanylation.
Methods Enzymol. 1977;47:129-32
PMID: 927170